Predicting the Benefit of Adjuvant Aromatase Inhibitor Therapy in Postmenopausal Breast Cancer Patients with Phosphorylated S6K1 Expression Status

Jihye Choi(Korea Institute of Radiological and Medical Sciences), Hyun‐Ah Kim(Korea Institute of Radiological and Medical Sciences)

Journal of Breast Cancer

January 1, 2020

10.4048/jbc.2020.23.e5

Cited by 6

Related Papers

Hansenula polymorpha Pmt4p Plays Critical Roles in O-Mannosylation of Surface Membrane Proteins and Participates in Heteromeric Complex Formation

|PLoS ONE|2015|11

pS6K1 as an efficacy marker of GnRH agonist with premenopausal breast cancer

|Endocrine Connections|2019|3